Moberg buys Sanofi's Balmex OTC brand in US

30 April 2015 - Deborah Wilkes

Archived

Sweden's Moberg Pharma has extended its OTC business in the US by acquiring the Balmex skincare brand from Sanofi for US$3.9 million.

Click tags below for more information on topics:

Moberg

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: